Zdrowie i gospodarka · 19/10/2018
FDA Classifies Intranasal Electrostimulation Device for Dry Eye Symptoms into Class II with Special Controls
The FDA has classified the intranasal electrostimulation device for dry eye symptoms into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →